MarineMax (HZO) director granted 5,000 options at $25.33 strike

MarineMax Form 4 shows a director-level option award for Odilon Almeida.

Rhea-AI Filing Summary

MarineMax Form 4 shows a director-level option award for Odilon Almeida. The filing records a grant of 5,000 options on 09/30/2025 with an exercise price of $25.33 and a ten-year contractual life through 09/30/2035. One-third of the options vest immediately, with the remaining two-thirds vesting in equal annual installments on 09/30/2026 and 09/30/2027. After the grant, the reporting person beneficially owns 5,000 shares underlying the option on a direct basis. The grant appears tied to director compensation and follows a standard multi-year vesting schedule.

Positive

• Clear disclosure of option terms including strike price, exercisability period and vesting schedule
• Partial immediate vesting (1/3) aligns the director with current company performance
• Modest grant size (5,000 options) likely limits dilution and is typical for director compensation

Negative

• No information provided about the aggregate number of outstanding options or total potential dilution from this grant relative to shares outstanding
• Grant value depends on future stock price performance; strike of $25.33 may be above current market, limiting near-term intrinsic value

Insights

Financial Analyst

TL;DR: A routine director option grant of 5,000 shares at $25.33 with staggered vesting; likely immaterial to valuation.

The award grants 5,000 options exercisable through 09/30/2035 at a $25.33 strike and vests 1/3 immediately, 1/3 in 2026 and 1/3 in 2027. For a company of typical market-cap scale, this size of grant is modest and represents standard equity-based compensation for non-employee directors. Immediate vesting of one-third aligns director incentives to act on current priorities while later tranches retain retention incentives. The reported direct beneficial ownership of 5,000 underlying shares post-grant is small in absolute terms and unlikely to materially affect outstanding share count or short-term EPS.

Corporate Governance Expert

TL;DR: Standard governance practice: equity grant to a director with time-based vesting; disclosure is complete and routine.

The Form 4 discloses the full terms: grant date, strike price, exercisability window and vesting schedule. The mix of immediate and time-based vesting is common for aligning board members with both current performance and longer-term oversight. No indications of accelerated vesting triggers, related-party transactions, or unusual transfer mechanics are present in the disclosure. From a governance perspective, this filing raises no material concerns but should be reviewed relative to the companys director compensation policy for proportionality.

Insider Trade Summary

Grant/Award: 0 shares

Grant/Award 1 txn

Insider Almeida Odilon

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (right to buy)	0	$0.00	$0.00

Holdings After Transaction: Options (right to buy) — 5,000 contracts (Direct)

Footnotes (1)

1. F1. Options vest as follows: 1/3 immediately, 1/3 on September 30, 2026 and 1/3 on September 30, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MarineMax insider Odilon Almeida receive according to the Form 4?

He received 5,000 stock options granted on 09/30/2025 with an exercise price of $25.33 and a term through 09/30/2035.

How do the options vest for Odilon Almeida at MarineMax (HZO)?

Vesting is 1/3 immediately, 1/3 on 09/30/2026 and 1/3 on 09/30/2027.

How many shares does Almeida beneficially own after the reported transaction?

Beneficial ownership of the underlying shares is 5,000 on a direct basis following the grant.

What is the exercise price and expiration for the awarded options?

Exercise price is $25.33 and the options expire on 09/30/2035.

Does the Form 4 indicate any unusual terms or accelerated vesting?

No unusual terms are disclosed; the filing shows a standard time-based vesting schedule and ordinary option mechanics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/01/2025 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Almeida Odilon

(Last) (First) (Middle)

501 BROOKER CREEK BLVD.

(Street)

OLDSMAR FL 34677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARINEMAX INC [ HZO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (right to buy)	$25.33	09/30/2025		A		$5,000		(1)	09/30/2035	Common Stock	5,000	$0	5,000	D

Explanation of Responses:

1. Options vest as follows: 1/3 immediately, 1/3 on September 30, 2026 and 1/3 on September 30, 2027.

	/s/ Anthony E. Cassella, Jr. as Attorney-in-Fact for Odilon Almeida	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.